Back to results
US 2025/0360102 A1Published application
Compositions and Methods for Radioprotectant/Radiomitigation Hybrid and/or Decorporation
OwnerSteven BARANOWITZinventor
Life of this patent
Estimating the term…
Abstract
Radioprotectant/radiomitigation hybrid material comprising at least one radiation absorbing component and at least one decorporation component. In particular, the hybrid material is composed of melanin and bismuth. The hybrid material may be formed into a pharmaceutical composition, medical device, protective armour, containers, equipment housing and the like. In another embodiment, a method for determining suitable decorporation materials for radioactive substances is also disclosed.
Claims29
A radioprotectant/radiomitigation hybrid pharmaceutical composition comprising:
- at least one therapeutically effective amount of a radiation absorbing component;
- at least one therapeutically effective amount of a decorporation material component;
- and at least one pharmaceutically acceptable excipient.
29-86. (canceled)
Dependencies are inferred from the claim text.